Advances in systemic therapy have improved survival of women with metastatic breast cancer. The Thomas et al1 analysis of Surveillance, Epidemiology, and End Results (SEER) data supports the concept that surgery may contribute to an outcome advantage by reducing the total body burden of disease. While this study’s overarching focus is indeed meaningful, it is also informative to place results from this report in the context of conversations regarding breast cancer disparities associated with racial/ethnic identity, young age, and country of origin.
Newman LA. Surgery for Stage IV Breast CancerDomestic and International Disparities. JAMA Surg. 2016;151(5):431. doi:10.1001/jamasurg.2015.4507